Vimarsana
Biggest News Aggregation in the World

Acid Modulators News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acid Modulators. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acid Modulators Today - Breaking & Trending Today

Xeris Biopharma Announces Recorlev® (levoketoconazole) Is Now Commercially Available for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing's Syndrome | Illinois - Vimarsana News

Xeris Biopharma Announces Recorlev® (levoketoconazole) Is Now Commercially Available for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing's Syndrome | Illinois

Published: January 31, 2022

CHICAGO--(BUSINESS WIRE)--Jan 31, 2022--

Source: wsiltv.com
Related Topics:
United StatesLindsay RoccoAllison WeyXeris BiopharmaStrongbridge BiopharmaXeris CareconnectionPaulr EdickKen JohnsonXeris PharmaceuticalsGlobal DevelopmentXeris Biopharma HoldingsXeris Pharmaceuticals IncPantherx RareElixir HealthDrug AdministrationPatient Assistance ProgramXeris Biopharma Holdings IncCorporate CommunicationsEuropean Medicines AgencyAffairs At XerisBiopharma HoldingsRare Specialty PharmacyMedical AffairsImportant Safety InformationP Gp Substrates
PANTHERx Rare® Selected by Xeris Pharmaceuticals to Distribute Recorlev® (levoketoconazole) for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome - Vimarsana News

PANTHERx Rare® Selected by Xeris Pharmaceuticals to Distribute Recorlev® (levoketoconazole) for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome

Published: January 13, 2022

/PRNewswire/ -- PANTHERx Rare announces that it has been selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc.,...

Source: prnewswire.com
Related Topics:
United StatesRob SnyderXeris BiopharmaAllyson AyoobXeris Pharmaceuticals IncAccreditation Commission For Health CareXeris Biopharma Holdings IncNational Association Of Specialty PharmacyEnvolve Pharmacy SolutionsXeris Biopharma HoldingsXeris PharmaceuticalsImportant Safety InformationP Gp SubstratesAcid ModulatorsFull Prescribing InformationSpecialty PharmacyNational AssociationAccredited DistinctionRare DiseasesOrphan DrugsAccreditation CommissionHealth CareChoice AwardBiopharma HoldingsPantherx Rare Pharmacy
PANTHERx Rare® Selected by Xeris Pharmaceuticals to Distribute Recorlev® (levoketoconazole) for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome - Vimarsana News

PANTHERx Rare® Selected by Xeris Pharmaceuticals to Distribute Recorlev® (levoketoconazole) for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome

Published: January 13, 2022

/PRNewswire/ -- PANTHERx Rare announces that it has been selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc.,...

Source: prnewswire.com
Related Topics:
United StatesRob SnyderXeris BiopharmaAllyson AyoobXeris Pharmaceuticals IncAccreditation Commission For Health CareXeris Biopharma Holdings IncNational Association Of Specialty PharmacyEnvolve Pharmacy SolutionsXeris Biopharma HoldingsXeris PharmaceuticalsImportant Safety InformationP Gp SubstratesAcid ModulatorsFull Prescribing InformationSpecialty PharmacyNational AssociationAccredited DistinctionRare DiseasesOrphan DrugsAccreditation CommissionHealth CareChoice AwardBiopharma HoldingsPantherx Rare Pharmacy
Xeris Biopharma Announces U.S. FDA Approval of Recorlev® (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing's Syndrome | Illinois - Vimarsana News

Xeris Biopharma Announces U.S. FDA Approval of Recorlev® (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing's Syndrome | Illinois

Published: December 31, 2021

CHICAGO--(BUSINESS WIRE)--Dec 30, 2021--

Source: wsiltv.com
Related Topics:
United StatesXeris BiopharmaLeslie EdwinXeris CareconnectionPaulr EdickAllison WeyLindsay RoccoLevoketoconazole RecorlevStrongbridge BiopharmaMaria FleseriuXeris Pharmaceuticals IncXeris PharmaceuticalsElixir HealthPituitary Center At Oregon Health Sciences UniversityDrug AdministrationXeris Biopharma Holdings IncCushing Support Research FoundationCorporate CommunicationsEuropean Medicines AgencyXeris Biopharma HoldingsBiopharma HoldingsNeurological SurgeryPituitary CenterOregon Health SciencesImportant Safety Information